ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard N. Gates
Hillel Laks
Davis C. Drinkwater, Jr
Abbas Ardehali
Alon S. Aharon
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gates, R. N.
Right arrow Articles by Chang, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gates, R. N.
Right arrow Articles by Chang, P. A.

Ann Thorac Surg 1995;60:1308-1311
© 1995 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Can Improved Microvascular Perfusion Be Achieved by Using Both Antegrade and Retrograde Cardioplegia?

Richard N. Gates, MD, Hillel Laks, MD, Davis C. Drinkwater, Jr, MD, Abbas Ardehali, MD, Alon S. Aharon, MD, Ana Maria Zaragoza, MD, Paul A. Chang, BS

Division of Cardiothoracic Surgery, Department of Surgery, and Department of Pathology, University of California, Los Angeles, Medical Center, Los Angeles, California

Accepted for publication June 23, 1995.

Background. The complete and uniform distribution of cardioplegia to the microvasculature of the heart is considered critical for myocardial protection. This study explores the hypothesis that enhanced microvascular perfusion can be achieved by using both antegrade and retrograde cardioplegia.

Methods. Infant piglet hearts (n = 15) were arrested with antegrade blood cardioplegia, excised, and fixed with 2.5% glutaraldehyde by retrograde perfusion. Hearts were then perfused retrograde with an inert intracapillary marker (NTB-2). Six of these hearts served as controls (group 1) to anatomically demonstrate the degree of capillary perfusion achieved by the retrograde delivery route. Nine experimental hearts (group 2) underwent a subsequent infusion of antegrade blood cardioplegia to wash out NTB-2 capillaries coperfused by both the antegrade and retrograde delivery techniques. Sections of the left ventricular free wall and anterior-mid interventricular septum were taken and examined by light microscopy at four separate sites (average, 126 capillaries per section).

Results. In control hearts, 91.9% ± 0.9% of ventricular capillaries and 91.4% ± 5.8% of septal capillaries were perfused by retrograde cardioplegia. After antegrade blood cardioplegia washed out group 2 hearts, 14.0% ± 4.1% of capillaries in the ventricle still contained NTB-2, as did 12.5% ± 5.4% of capillaries in the septum.

Conclusions. In this experimental model, antegrade blood cardioplegia did not coperfuse (and therefore washout) 12.5% to 14% (p < 0.05) of capillaries perfused by retrograde cardioplegia. This suggests that an additional 12.5% to 14% of capillaries within the myocardium may receive cardioplegia if retrograde cardioplegia is used in addition to antegrade cardioplegia. We conclude that by combining both antegrade and retrograde cardioplegia, there is a potential for enhanced overall microvascular perfusion.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Onorati, A. Renzulli, M. De Feo, G. Santarpino, R. Gregorio, A. Biondi, F. Cerasuolo, and M. Cotrufo
Does antegrade blood cardioplegia alone provide adequate myocardial protection in patients with left main stem disease?
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1345 - 1351.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Ruengsakulrach and B. F. Buxton
Anatomic and hemodynamic considerations influencing the efficiency of retrograde cardioplegia
Ann. Thorac. Surg., April 1, 2001; 71(4): 1389 - 1395.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Oriaku, B. Xiang, G. Dai, J. Shen, J. Sun, W. G. Lindsay, R. Deslauriers, and G. Tian
EFFECTS OF RETROGRADE CARDIOPLEGIA ON MYOCARDIAL PERFUSION AND ENERGY METABOLISM IN IMMATURE PORCINE MYOCARDIUM
J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1102 - 1109.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. B. Ericsson, S. Takeshima, and J. Vaage
Simultaneous Antegrade And Retrograde Delivery Of Continuous Warm Blood Cardioplegia After Global Ischemia
J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 716 - 722.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. N. Gates, J. Lee, H. Laks, D. C. Drinkwater Jr, E. Rhudis, A. S. Aharon, J. Y. Chung, and P. A. Chang
Evidence of Improved Microvascular Perfusion When Using Antegrade and Retrograde Cardioplegia
Ann. Thorac. Surg., November 1, 1996; 62(5): 1388 - 1391.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
I. B. Krukenkamp and S. Levitsky
Myocardial Protection: Modern Studies
Ann. Thorac. Surg., May 1, 1996; 61(5): 1581 - 1582.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.